Search filters

List of works by Christopher J Scott

A Novel Role for Cathepsin S as a Potential Biomarker in Triple Negative Breast Cancer

scientific article published on 27 June 2019

Anti-DLL4 VNAR targeted nanoparticles for targeting of both tumour and tumour associated vasculature

scientific article published on 06 July 2020

Antibody Targeting of Cathepsin S Inhibits Angiogenesis and Synergistically Enhances Anti-VEGF

scientific article (publication date: 2 September 2010)

Antibody-Targeted Nanoparticles for Cancer Therapy

scientific article published on March 1, 2011

Comprehensive inhibitor profiling of the Proteus mirabilis metalloprotease virulence factor ZapA (mirabilysin)

scientific article published on July 6, 2011

Controlled coupling of an ultrapotent auristatin warhead to cetuximab yields a next-generation antibody-drug conjugate for EGFR-targeted therapy of KRAS mutant pancreatic cancer

scientific article published on 11 September 2020

Inhibition of Cathepsin S by Fsn0503 enhances the efficacy of chemotherapy in colorectal carcinomas

scientific article published on August 31, 2011

Nanodelivery strategies for the treatment of multidrug-resistant bacterial infections

scientific article published on 04 September 2018

Procathepsin V Is Secreted in a TSH Regulated Manner from Human Thyroid Epithelial Cells and Is Accessible to an Activity-Based Probe

scientific article published on 30 November 2020

Refined construction of antibody-targeted nanoparticles leads to superior antigen binding and enhanced delivery of an entrapped payload to pancreatic cancer cells

scientific article published on 21 May 2020

Repurposing of Cetuximab in antibody-directed chemotherapy-loaded nanoparticles in EGFR therapy-resistant pancreatic tumours

scientific article published on 18 October 2019

The deubiquitinating enzyme USP17 is essential for GTPase subcellular localization and cell motility

scientific article published on March 29, 2011